Detalhe da pesquisa
1.
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia.
Intern Med J
; 51(10): 1707-1712, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664367
2.
The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit.
Am J Hematol
; 90(5): E86-91, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25651830
3.
Consensus statement on the treatment of transplant-eligible patients with newly diagnosed multiple myeloma in New Zealand.
N Z Med J
; 133(1527): 104-110, 2020 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332332
4.
Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial.
J Clin Oncol
; 34(30): 3609-3617, 2016 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27325857
5.
Identification of JAK2V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia vera.
Am J Hematol
; 82(1): 80-2, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16924638